Evidence map›Paper›PMID 30596665›Full record

ArticlePloS one2018

The immunological function of extracellular vesicles in hepatitis B virus-infected hepatocytes.

Masatoshi Kakizaki, Yuichiro Yamamoto, Suemi Yabuta, Natsumi Kurosaki, Tatehiro Kagawa, Ai Kotani

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. The PD-1/PD-L1 pathway and Epstein-Barr virus.European journal of medical research · 2025
    Review
  7. Article
  8. Article
  9. Exosome in HBV infection: current concepts and future perspectives.Frontiers in cellular and infection microbiology · 2025
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Masatoshi KakizakiDivision of Hematological Malignancy, Institute of Medical Sciences, Tokai University, Isehara, Japan.
Yuichiro YamamotoDivision of Hematological Malignancy, Institute of Medical Sciences, Tokai University, Isehara, Japan.
Suemi YabutaDivision of Hematological Malignancy, Institute of Medical Sciences, Tokai University, Isehara, Japan.ORCID 0000-0003-3124-3606
Natsumi KurosakiDepartment of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
Tatehiro KagawaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.
Ai KotaniDivision of Hematological Malignancy, Institute of Medical Sciences, Tokai University, Isehara, Japan.ORCID 0000-0002-0976-8687
Tokai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis B virus (HBV) generates large amounts of complete and incomplete viral particles. Except for the virion, which acts as infectious particles, the function of those particles remains elusive. Extracellular vesicles (EVs) have been revealed to have biological functions. The EVs which size are less than 100 nm in diameter, were collected from HBV infected-patients. These vesicles contain, complete and incomplete virions, and exosomes, which have been recently shown to be critical as intercellular communicators. Here, the effects of the exosome, the complete, and the incomplete particles on the target cells were investigated. These particles are endocytosed by monocyte/macrophages and function primarily to upregulate PD-L1. The functions and composition of the EVs were affected by nucleotide reverse transcriptase inhibitors (NRTIs), suggesting that the EVs are involved in the pathogenesis of HBV hepatitis and clinical course of those patients treated by NRTIs.

Indexed as

Up-RegulationB7-H1 AntigenCell LineExtracellular VesiclesHemangioendotheliomaHepatitis BHepatitis B virusB7-H1 AntigenCD274 protein, human

Identifiers

PMID30596665
PMCPMC6312312
OpenAlexW2906779152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.